Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Nov 19, 2019)
Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019
This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare.
Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.
What just happenedNov 19, 2019
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673)
Who’s behind it
- Introduced in SenateNov 19, 2019
- Nov 19, 2019IntroReferral
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673)
Finance Committee - Nov 19, 2019IntroReferral10000
Introduced in Senate